Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis.
about
Risk impact of edoxaban in the management of stroke and venous thromboembolismRisk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational StudiesNon-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials.Outcomes After Cardioversion in Atrial Fibrillation Patients Treated with Non-Vitamin K Antagonist Oral Anticoagulants (NOACs): Insights from a Meta-Analysis.Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis.Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.Prognosis in patients with atrial fibrillation and a presumed "temporary cause" in a community-based cohort study.Rationale and design of the RE-LATED AF--AFNET 7 trial: REsolution of Left atrial-Appendage Thrombus--Effects of Dabigatran in patients with Atrial Fibrillation.Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre.Direct Oral Anticoagulants in Cardioversion: A Review of Current Evidence.Evaluating cardioversion outcomes for atrial fibrillation on novel oral anticoagulants versus warfarin: experience at a tertiary referral centre.
P2860
Q26738846-69F0190E-FF19-4E11-88BF-4CE36BBA3177Q28078747-44B0AB00-19FA-4B7B-8B1C-C405D1E9B2C7Q34672746-02A013DE-BAF3-48BA-80AE-A82112BA3797Q35681742-4B76C88F-B8F8-4A46-B1B3-29C7E800A930Q36240734-70D37E7A-8DAB-44D8-9573-36261B2E54A9Q38975409-A53BDF6C-AD9D-4008-B0CF-DE3A75F0A206Q40556805-8E00F585-C459-468E-9449-48D67BB12438Q40799525-469E716B-3A66-4510-A81C-49C7DAD14FC5Q41564940-F33E20EA-A973-4AC5-8D35-1FFCE55F28A4Q47741252-E5AE8C8B-61F6-423D-8193-B462B6ADE670Q50875460-9B4ADC4B-C2CB-4B63-8F71-80C19FFD96E1
P2860
Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Non-vitamin K antagonist oral ...... atic review and meta-analysis.
@ast
Non-vitamin K antagonist oral ...... atic review and meta-analysis.
@en
type
label
Non-vitamin K antagonist oral ...... atic review and meta-analysis.
@ast
Non-vitamin K antagonist oral ...... atic review and meta-analysis.
@en
prefLabel
Non-vitamin K antagonist oral ...... atic review and meta-analysis.
@ast
Non-vitamin K antagonist oral ...... atic review and meta-analysis.
@en
P2093
P2860
P1476
Non-vitamin K antagonist oral ...... matic review and meta-analysis
@en
P2093
Gregory Y H Lip
Joaquim J Ferreira
João Costa
P2860
P2888
P304
P356
10.1007/S00392-015-0821-8
P577
2015-02-03T00:00:00Z